首页> 外国专利> Use of an agent that Inhibits the signals through programmed Death 1 (pd-1)In this way submodular Activation of an immune cell because it is for the manufacture of a Medicament for the Treatment or prevention of immune disorders, autoimmuneAllergies or Viral Infections.

Use of an agent that Inhibits the signals through programmed Death 1 (pd-1)In this way submodular Activation of an immune cell because it is for the manufacture of a Medicament for the Treatment or prevention of immune disorders, autoimmuneAllergies or Viral Infections.

机译:使用通过程序性死亡1(pd-1)抑制信号的试剂的使用这种方式使免疫细胞亚模块激活,因为它是用于制造用于治疗或预防免疫疾病,自身免疫过敏或病毒感染的药物。

摘要

Method for submodular an immune response that includes putting an immune cell in contact with an agent Module interactions between pd-1 and pd-1 ligand (e.g.Soluble forms of pd-1 or Antibodies against pd-1) to modulate the immune response.
机译:亚模块免疫应答的方法,该方法包括使免疫细胞与试剂接触pd-1和pd-1配体(例如pd-1的可溶性形式或抗pd-1的抗体)之间的模块相互作用来调节免疫应答。

著录项

  • 公开/公告号CL2002000607A1

    专利类型

  • 公开/公告日2002-12-09

    原文格式PDF

  • 申请/专利权人 WYETH;

    申请/专利号CL2002000607

  • 申请日2002-03-27

  • 分类号A61K38/12;A61K39/395;C07K14/705;C07K16/28;

  • 国家 CL

  • 入库时间 2022-08-22 00:03:37

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号